Anogenital cancers testing in Worcester
Find health labs to test for Anogenital cancers in Worcester and compare all offers by prices and services.
Tests that cover Anogenital cancers
HPV Test
Pap Smear by Selly Oak Health Centre
15 Katie Road, Birmingham, B29 6JG, United Kingdom
24 km
Pap Smear by Midlands Gynaecology
22 Somerset Road, Birmingham, B15 2QQ, United Kingdom
24 km
HPV Test by Midland Health Private GP
23a Highfield Road, Birmingham, B15 3, United Kingdom
24 km
Unverified
A HPV Test costs £243.00
See Details
HPV Test by Edgbaston Private Medical Practice
44 George Road, Birmingham, B15 1PL, United Kingdom
24 km
Unverified
A HPV Test costs £250.00
See Details
HPV Test by Clarewell Clinics (Private Sexual Health Clinic London)
40 Hylton Street, Birmingham, B18 6HN, United Kingdom
24 km
Unverified
A HPV Test costs £250.00
See Details
Pap Smear by St Jude's Womens Hospital
263 Penn Road, Wolverhampton, WV4 4, United Kingdom
27.3 km
Unverified
A HPV Test costs £365.00
See Details
Pap Smear by The Royal School Wolverhampton
11 Park Road West, Wolverhampton, WV1 4, United Kingdom
27.3 km
HPV Test by Tudor Medical Centre
1 Tudor Road, Wolverhampton, WV10 0LS, United Kingdom
27.3 km
Pap Smear by The Royal School Wolverhampton
10 Wolverhampton Road, Wolverhampton, WV8 1, United Kingdom
27.3 km
HPV Test by Midlands Gynaecology
Little Aston Hall, Sutton Coldfield, B74 3, United Kingdom
30.6 km
Anogenital cancers - symptoms and how to test
Human papillomavirus (HPV) infection is linked to anogenital malignancies, namely to the alpha genus of mucosal HPV types 16 and 1810,11. There is some evidence that beta-genus HPVs contribute to cutaneous SCC, although it is inconclusive. High-risk HPVs account for 3% of all female malignancies and 2% of all male cancers in the United States. The Centers for Disease Control and Prevention report that each year there are around 45,000 new instances of cancer in areas of the body where HPV is often present. HPV is predicted to cause approximately 36,000 of these (CDC). The HPV test screens for the presence of high-risk HPV strains that are associated with an increased risk of developing cervix precancers and malignancies.
